Literature DB >> 25765284

PKA-type I selective constrained peptide disruptors of AKAP complexes.

Yuxiao Wang1, Tienhuei G Ho1, Eugen Franz2, Jennifer S Hermann2, F Donelson Smith3, Heidi Hehnly3, Jessica L Esseltine3, Laura E Hanold1, Mandi M Murph1, Daniela Bertinetti2, John D Scott3, Friedrich W Herberg2, Eileen J Kennedy1.   

Abstract

A-Kinase Anchoring Proteins (AKAPs) coordinate complex signaling events by serving as spatiotemporal modulators of cAMP-dependent protein kinase activity in cells. Although AKAPs organize a plethora of diverse pathways, their cellular roles are often elusive due to the dynamic nature of these signaling complexes. AKAPs can interact with the type I or type II PKA holoenzymes by virtue of high-affinity interactions with the R-subunits. As a means to delineate AKAP-mediated PKA signaling in cells, we sought to develop isoform-selective disruptors of AKAP signaling. Here, we report the development of conformationally constrained peptides named RI-STapled Anchoring Disruptors (RI-STADs) that target the docking/dimerization domain of the type 1 regulatory subunit of PKA. These high-affinity peptides are isoform-selective for the RI isoforms, can outcompete binding by the classical AKAP disruptor Ht31, and can selectively displace RIα, but not RIIα, from binding the dual-specific AKAP149 complex. Importantly, these peptides are cell-permeable and disrupt Type I PKA-mediated phosphorylation events in the context of live cells. Hence, RI-STAD peptides are versatile cellular tools to selectively probe anchored type I PKA signaling events.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25765284      PMCID: PMC4475429          DOI: 10.1021/acschembio.5b00009

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  66 in total

1.  Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP-dependent protein kinase.

Authors:  S Barradeau; T Imaizumi-Scherrer; M C Weiss; D M Faust
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes.

Authors:  M G Newlon; M Roy; D Morikis; D W Carr; R Westphal; J D Scott; P A Jennings
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 3.  The essential role of RI alpha in the maintenance of regulated PKA activity.

Authors:  Paul S Amieux; G Stanley McKnight
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 4.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

5.  Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor.

Authors:  Cathrine Rein Carlson; Birgitte Lygren; Torunn Berge; Naoto Hoshi; Wei Wong; Kjetil Taskén; John D Scott
Journal:  J Biol Chem       Date:  2006-05-25       Impact factor: 5.157

6.  Sphingosine kinase interacting protein is an A-kinase anchoring protein specific for type I cAMP-dependent protein kinase.

Authors:  Duangnapa Kovanich; Marcel A G van der Heyden; Thin Thin Aye; Toon A B van Veen; Albert J R Heck; Arjen Scholten
Journal:  Chembiochem       Date:  2010-05-03       Impact factor: 3.164

7.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

8.  The molecular basis for protein kinase A anchoring revealed by solution NMR.

Authors:  M G Newlon; M Roy; D Morikis; Z E Hausken; V Coghlan; J D Scott; P A Jennings
Journal:  Nat Struct Biol       Date:  1999-03

9.  Expression of cDNAs for two isoforms of the catalytic subunit of cAMP-dependent protein kinase.

Authors:  M D Uhler; G S McKnight
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

10.  Isoform-selective disruption of AKAP-localized PKA using hydrocarbon stapled peptides.

Authors:  Yuxiao Wang; Tienhuei G Ho; Daniela Bertinetti; Matthias Neddermann; Eugen Franz; Gary C H Mo; Lewis P Schendowich; Avinash Sukhu; Raybun C Spelts; Jin Zhang; Friedrich W Herberg; Eileen J Kennedy
Journal:  ACS Chem Biol       Date:  2014-01-21       Impact factor: 5.100

View more
  18 in total

1.  Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Authors:  Thomas M Moon; Nathan R Tykocki; Jessica L Sheehe; Brent W Osborne; Werner Tegge; Joseph E Brayden; Wolfgang R Dostmann
Journal:  Chem Biol       Date:  2015-12-17

2.  Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide.

Authors:  Briana R Flaherty; Tienhuei G Ho; Sven H Schmidt; Friedrich W Herberg; David S Peterson; Eileen J Kennedy
Journal:  ACS Infect Dis       Date:  2019-02-18       Impact factor: 5.084

Review 3.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

4.  AKAP18:PKA-RIIα structure reveals crucial anchor points for recognition of regulatory subunits of PKA.

Authors:  Frank Götz; Yvette Roske; Maike Svenja Schulz; Karolin Autenrieth; Daniela Bertinetti; Katja Faelber; Kerstin Zühlke; Annika Kreuchwig; Eileen J Kennedy; Gerd Krause; Oliver Daumke; Friedrich W Herberg; Udo Heinemann; Enno Klussmann
Journal:  Biochem J       Date:  2016-04-21       Impact factor: 3.857

5.  Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.

Authors:  Melody D Fulton; Laura E Hanold; Zheng Ruan; Sneha Patel; Aaron M Beedle; Natarajan Kannan; Eileen J Kennedy
Journal:  Bioorg Med Chem       Date:  2017-09-05       Impact factor: 3.641

Review 6.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

7.  Defining A-Kinase Anchoring Protein (AKAP) Specificity for the Protein Kinase A Subunit RI (PKA-RI).

Authors:  Karolin Autenrieth; N George Bendzunas; Daniela Bertinetti; Friedrich W Herberg; Eileen J Kennedy
Journal:  Chembiochem       Date:  2015-12-17       Impact factor: 3.164

Review 8.  Designing helical peptide inhibitors of protein-protein interactions.

Authors:  Raheleh Rezaei Araghi; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2016-04-25       Impact factor: 6.809

Review 9.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

Review 10.  The genetically encoded tool set for investigating cAMP: more than the sum of its parts.

Authors:  Neha Patel; Matthew G Gold
Journal:  Front Pharmacol       Date:  2015-08-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.